Is Anticoagulant Therapy Too Frequently Used in Ischemic Stroke?

Abstract

Heparin therapy is currently used throughout industrialized countries to, treat the acute phase of stroke. It is astonishing to consider the disparity between the lack of large-scale multicenter controlled trials for heparin therapy and the proliferation of aspirin trials throughout the world. Perhaps with the launching of the new low-molecular-compound heparins, there will be opportunity to set up trial in order to try establishing the indications for early anticoagulation.